Antibody Characterization Report for Charged multivesicular body protein 2b

A peer-reviewed antibody characterization article corresponding to this Zenodo preprint is openly available at F1000Research: https://doi.org/10.12688/f1000research.139755.1 Head-to-head comparison of available commercial antibodies against Charged multivesicular body protein 2b by immunoblot (Western blot), immunoprecipitation and immunofluorescence. This work was supported in part by the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.

Related Organizations

Keywords

Vps2-2, amyotrophic lateral sclerosis, antibody characterization, YCharOS, Chromatin-modifying protein 2b, Vacuolar protein sorting-associated protein 2-2, CHMP2B, Q9UQN3, antibody validation, ALS-RAP, Charged multivesicular body protein 2b

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	1
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average